HIV Rapid Diagnostic Test Inventories in Zambézia Province, Mozambique: A Tale of 2 Test Kits

Document Type : Original Article


1 Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN, USA

2 Friends in Global Health, Department of Pharmacy, Quelimane, Mozambique

3 Provincial Health Directorate, Quelimane, Mozambique

4 Vanderbilt Institute for Global Health, Department of Medicine, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN, USA

5 Friends in Global Health, Maputo, Mozambique

6 Vanderbilt Institute for Global Health, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA

7 Vanderbilt Institute for Global Health, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA


The first pillar of the UNAIDS 90-90-90 goal seeks to accurately identify persons living with HIV (PLHIV), a process that is predicated on facilities having the necessary HIV tests available to perform the task. In many rural settings, the identification of PLHIV is accomplished through a two-step process involving the sequential use of 2 separate rapid diagnostic tests (RDTs). Inadequate inventory of either test has ramifications for the success of HIV-related programs. The purpose of this study was to evaluate the inventory levels of HIV RDT kits at specific healthcare facilities in Zambézia province, Mozambique.
Using facility-level pharmacy stock surveillance data from October 2015 through September 2016, we assessed the inventory levels of HIV RDTs at 75 health facilities in 8 districts within Zambézia province, Mozambique. Using programmatically established categories (good, sufficient, threatened, or stockout), defined in conjunction with the provincial health authorities, descriptive statistics were performed to determine inventory control of HIV RDTs at the district and health facility levels. Monthly proportions of adequate (good + sufficient) inventory were calculated for each district to identify inventory trends over the evaluation period. To assess whether the proportion of inadequate stocks differed between RDT, a mixed-effects logistic regression was conducted, with inadequate inventory status as the outcome of interest.
When viewed as a whole, the inventory of each test kit was reported as being at adequate levels more than 89% of the time across the 75 facilities. However, disaggregated analysis revealed significant variability in the inventory levels of HIV RDTs at the district level. Specifically, the districts of Inhassunge, Namacurra, and Pebane reported inadequate inventory levels (threatened + stockout), of one or both test kits, for more than 10% of the study period. In addition, a disparity between inventory levels of each test kit was identified, with the odds of reporting inadequate inventory levels of the confirmatory test (Uni-Gold™) being approximately 1.8-fold greater than the initial test (Determine™) (odds ratio: 1.82, 95% CI: 1.40-2.38).
As Test and Treat programs evolve, a significant emphasis should be placed on the “test” component of the strategy, beginning with assurances that health facilities have the adequate inventory of RDT necessary to meet the needs of their community. As national policy-makers rely predominantly on data from the upstream arm of the supply chain, it is unlikely the disparity between inventory levels of HIV RDTs identified at individual districts and specific health facilities would have been recognized. Moving forward, our findings point to a need for (1) renewed efforts reinforcing appropriate downstream forecasting of essential medicines and diagnostic tests in general and for Uni-Gold™ test kits specifically, and (2) simple metrics that may be routinely collected at all health facilities and which may then easily and quickly flow upstream so that policy-makers may optimally allocate resources.


Supplementray File 1 (Download)


Main Subjects

  1. United Nations. Revised list of global Sustainable Development Goal indicators.  Accessed February 8, 2019.
  2. UNAIDS. 2016-2021 Strategy: On the Fast Track to End AIDS.  Accessed February 8, 2019.
  3. U.S. Department of Health and Human Services. HSRA Care Action. Test and Treat: A New Paradigm for Slowing the Spread of HIV.  Published January 2012. Accessed February 8, 2019.
  4. World Health Organization (WHO). Progress Report 2016: Prevent HIV, Test and Treat All: WHO Support for Country Impact.  Accessed February 8, 2019.
  5. UNAIDS 2014: 90-90-90 An ambitious treatment target to help end the AIDS epidemic.  Accessed February 8, 2019.
  6. Jamieson D, Kellerman SE. The 90 90 90 strategy to end the HIV pandemic by 2030: Can the supply chain handle it? J Int AIDS Soc. 2016;19(1):20917. doi: 10.7448/IAS.19.1.20917
  7. UNAIDS. Global HIV & AIDS statistics – 2018 fact sheet.  Accessed February 8, 2019.
  8. UNAIDS. Ending AIDS: Progress Towards the 90-90-90 Targets. Global AIDS Update 2017.  Accessed February 8, 2019.
  9. UNAIDS. 90-90-90: On the right track towards the global target. 2016.  Accessed February 8, 2019.
  10. UNICEF. HIV Diagnosis: A Guide for Selecting Rapid Diagnostic Test (RDT) Kits.  Accessed on February 8, 2019. Published 2008.
  11. USAID DELIVER PROJECT. Quantification of Health Commodities: HIV Test Kit Companion Guide. Forecasting Consumption of HIV Test Kits. . Accessed February 8, 2019. Published 2008.
  12. USAIDS DELIVER 2004. Supply chain management implications for HIV/AIDS policymakers and program managers. . Accessed February 8, 2019.
  13. USAID DELIVER PROJECT 2011. Logistics Handbook: A Practical Guide for the Supply Chain Management of Health Commodities. Task Order 1.  Accessed February 8, 2019.
  14. John Snow, Inc. The Supply Chain Manager’s Handbook, A Practical Guide to the Management of Health Commodities.  Accessed on February 8, 2019. Published 2017.
  15. World Health Organization (WHO). Consolidated Guidelines on HIV Testing Services. 5Cs: Consent, Confidentiality, Counseling, Correct Results and Connection.  Accessed February 8, 2019. Published 2015.
  16. Directriz Nacional Para a Implementtação do Aconselhamento e Testagem em Moçambique.  Accessed February 8, 2019. Published 2015.
  17. Vermund SH, Blevins M, Moon TD, et al. Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: Need for program quality improvement and community engagement. PLoS One. 2014;9(10):e110116.
  18. PEPFAR. Mozambique Operational Plan (COP/ROP) 2017: Strategic Direction Summary.  Accessed February 8, 2019.
  19. Moon TD, Burlison JR, Sidat M, et al. 2010. Lessons Learned while Implementing an HIV/AIDS Care and Treatment Program in Rural Mozambique. Retrovirology (Auckl). 2010;3:1-14. doi:10.4137/RRT.S4613
  20. HIV/AIDS Key Indicator Report, Mozambique IMASIDA 2015.  Accessed February 8, 2019.
  21. UNAIDS DATA 2017.  Accessed February 8, 2019.
  22. PEPFAR Mozambique. Partnering to Achieve HIV/AIDS Epidemic Control.  Accessed on February 8, 2019. Published 2018.
  23. Spisak C, Morgan L, Eichler R, et al. Results-Based Financing in Mozambique’s Central Medical Store: A Review after 1-year. Glob Health Sci Pract. 2016;4(1):165-177.
  24. USAID Global Health Supply Chain Program. Procurement and Supply Management Project. Semi-annual and Quarterly report.  Accessed February 8, 2019. Published July 29, 2016.
  25. Wagenaar BH, Gimbel S, Hoek R, et al. Stock-outs of essential health products in Mozambique – longitudinal analysis from 2011 to 2013. Trop Med Int Health. 2014;19(7):791-801. doi:10.1111/tmi.12314
  26. Hasselback L, Crawford J, Chaluco T, et al. Rapid diagnostic test supply chain and consumption study in Cabo Delgado, Mozambique: estimating stock shortages and identifying drivers of stock-outs. Malaria J. 2014;13:295.
  27. Halperin D, Wilson D. “Know your epidemic, know your response”: a useful approach, if we get it right. Lancet. 2008;372(9637):423-426. doi:10.1016/S0140-6736(08)60883-1
  28. Berhanemeskel E, Beedmariam G, Fenta TG. 2016. HIV/AIDS related commodities supply chain management in public health facilities of Addis Ababa, Ethiopia: a cross-sectional survey. J Pharm Policy Pract. 2016;9:11.
  29. Audit Report: Global Fund Grants to the Democratic Republic of Congo.  Accessed February 8, 2019. Published 2016.
  30. USAID Deliver Project. Final Country Report: Mozambique. 2016.  Accessed February 8, 2019.
Volume 8, Issue 5
May 2019
Pages 292-299
  • Receive Date: 06 June 2018
  • Revise Date: 08 February 2019
  • Accept Date: 10 February 2019
  • First Publish Date: 01 May 2019